6. Diagnostisering

Abbasi, N. R., Shaw, H. M., Rigel, D. S., Friedman, R. J., McCarthy, W. H., Osman, I., ... Polsky, D. (2004). Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA, 292(22), 2771-6.

Bristow, I. R., de Berker, D. A., Acland, K. M., Turner, R. J., & Bowling, J. (2010). Clinical guidelines for the recognition of melanoma of the foot and nail unit. Journal of foot and ankle research, 3, 25.

Chakera, A. H., Hesse, B., Burak, Z., Ballinger, J. R., Britten, A., Caraco, C., ... Testori, A. (2009). EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. European journal of nuclear medicine and molecular imaging, 36(10), 1713-42.

Clark, W. H. ,. J., Elder, D. E., Guerry, D. t., Braitman, L. E., Trock, B. J., Schultz, D., ... Halpern, A. C. (1989). Model predicting survival in stage I melanoma based on tumor progression. Journal of the National Cancer Institute, 81(24), 1893-904.

Clark, W. H. ,. J., From, L., Bernardino, E. A., & Mihm, M. C. (1969). The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer research, 29(3), 705-27.

Cook, M. G., Massi, D., Szumera-Ciećkiewicz, A., Van den Oord, J., Blokx, W., van Kempen, L. C., ... van Akkooi, A. C. J. (2019). An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma. European journal of cancer, 114, 1-7.

Daud, A. I., Wolchok, J. D., Robert, C., Hwu, W. J., Weber, J. S., Ribas, A., ... Hamid, O. (2016). Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma. Journal of clinical oncology, 34(34), 4102-4109.

Friedman, R. J., Rigel, D. S., & Kopf, A. W. (1985). Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA: a cancer journal for clinicians, 35(3), 130-51.

Gershenwald, J. E., Scolyer, R. A., Hess, K. R., Sondak, V. K., Long, G. V., Ross, M. I., ... Thompson, J. F. (2017). Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: a cancer journal for clinicians, 67(6), 472-492.

Goodson, A. G., & Grossman, D. (2009). Strategies for early melanoma detection: Approaches to the patient with nevi. Journal of the American Academy of Dermatology, 60(5), 719-35; quiz 736-8.

Jefferson, J., & Rich, P. (2012). Melanonychia. Dermatology research and practice, 2012, 952186.

Jellinek, N. (2007). Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. Journal of the American Academy of Dermatology, 56(5), 803-10.

Kelly, J. W., Chamberlain, A. J., Staples, M. P., & McAvoy, B. (2003). Nodular melanoma. No longer as simple as ABC. Australian family physician, 32(9), 706-9.

Keung, E. Z., & Gershenwald, J. E. (2018). The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert review of anticancer therapy, 18(8), 775-784.

Kittler, H., Pehamberger, H., Wolff, K., & Binder, M. (2002). Diagnostic accuracy of dermoscopy. The Lancet. Oncology, 3(3), 159-65.

Kreftregisteret (09. juni 2022). Nasjonalt kvalitetsregister for melanom. [nettside]. Oslo: Kreftregisteret. Hentet 17. oktober 2022 fra https://www.kreftregisteret.no/Registrene/Kvalitetsregistrene/Register-for-melanom/

Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J., Rutkowski, P., Lao, C. D., ... Wolchok, J. D. (2019). Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. The New England journal of medicine, 381(16), 1535-1546.

Levit, E. K., Kagen, M. H., Scher, R. K., Grossman, M., & Altman, E. (2000). The ABC rule for clinical detection of subungual melanoma. Journal of the American Academy of Dermatology, 42(2 Pt 1), 269-74.

Littleton, T. W., Murray, P. M., & Baratz, M. E. (2019). Subungual Melanoma. The Orthopedic clinics of North America, 50(3), 357-366.

Mihm, M. C. ,. J., & Mule, J. J. (2015). Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response. Cancer immunology research, 3(8), 827-35.

Nakamura, Y., & Fujisawa, Y. (2018). Diagnosis and Management of Acral Lentiginous Melanoma. Current treatment options in oncology, 19(8), 42.

Ng, J. C., Swain, S., Dowling, J. P., Wolfe, R., Simpson, P., & Kelly, J. W. (2010). The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Archives of dermatology, 146(3), 234-9.

Ohn, J., Jo, G., Cho, Y., Sheu, S. L., Cho, K. H., & Mun, J. H. (2018). Assessment of a Predictive Scoring Model for Dermoscopy of Subungual Melanoma In Situ. JAMA dermatology, 154(8), 890-896.

Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., ... Lamina, T. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology, 80(1), 208-250.

Vestergaard, M. E., Macaskill, P., Holt, P. E., & Menzies, S. W. (2008). Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. The British journal of dermatology, 159(3), 669-76.

Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., ... Ascierto, P. A. (2017). Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. The New England journal of medicine, 377(19), 1824-1835.